Gastric & Breast Cancer
DOI: 10.2122/gbc.2003.0024
PERSPECTIVE
|
Evidence-based
Approach: Is it Time to Change Funding, Research Policy
and Treatment Strategy of Gastric Cancer in the Western
World? |
Abstract |
Little
progress has been made in the treatment of gastric
cancer during the last decades in the USA. Public
health efforts and research at improving survival
have exclusively been focused on expensive multimodality
therapies funded by industry rather than strong quality
control of surgery. Currently, convincing evidence
indicates the paramount importance of surgeon volume
and technical skill in improving patient outcomes.
|
Now,
a multicenter Japanese randomized controlled trial
(RCT) providing fascinating findings for the ability
of surgery with appropriate extensive lymph node dissection
to control serosa-negative cancer, strongly questions
current treatment practice in the West. . |
Considering
advances in understanding the patterns of recurrences
after primary tumor resection and growing evidence
for the ability of high-quality surgery to improve
survival, should we change current treatment strategy
and research policy on stage-specific inclusion
of patients in multimodality perioperative therapeutics
protocols?
|
|
|
|
Find Delta Dental, MetLife Dental, Aetna Dentist, New York Dentist, San Francisco Dentist, Boston Dentist, Chicago Dentist, Los Angeles Dentist & San Diego Dentist at DoctorsImprovingHealthcare.org.
Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy and
confidentiality of information and transparency
of sponsorship
last
update: 12 December 2003 |
|
|
|
